Beijing's new 118 million investment market

More and more money to the housing market, even pharmaceutical companies to join the ranks of the rise in gambling properties. BEIJING, the new drug industry issued a notice last night, in order to put the management headquarters and sales headquarters in Hangzhou office, the company intends to spend 118 million yuan to purchase the 24th, 25 floors, two floors and 8 parking spaces in the building B of UDC times, with a total area of 3025.52 square meters.　　Among them, the purchase of the first floor of the new drug industry as the future headquarters office use, the other layer as an investment property.　　According to the announcement, the above property, the 24-storey unit price of 38220 yuan/square meters, 25-storey unit price of 38510 yuan/square meters, the price of each parking space is 250,000 yuan.　　This price is slightly higher than the average of the other offices in the lot.　　Beijing New drug Industry said that the company's own funds have 60 million yuan, the first payment of the transaction 60 million yuan, of which 30 million yuan to own funds to pay, another 30 million yuan to be resolved through bank loans.　　The announcement also said that the transaction is conducive to the company's headquarters management upgrade, but short-term to the company constituted a certain financial pressure, Beijing New drug industry is expected to increase the annual financial costs of about 6.3 million yuan, increase depreciation of about 3.4 million yuan, the total impact of profit of about 9.7 million yuan.　　To this end, the Beijing new drug industry, said to reduce the pressure on payment, the company plans to sell located in Hangzhou, No. No. 203, Chao Hui Road, Hangzhou Blue Square, the 15th floor office, and the foregoing another layer of investment property rental to obtain rental income. Yesterday, Beijing's new drug industry closed at 14.09 Yuan, up 1.29%.